Trial Profile
A randomized, double-blind study to asses beneficial effects of varenicline plus low dose naltrexone in subjects with heavy drinking and smoking.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2015
Price :
$35
*
At a glance
- Drugs Naltrexone (Primary) ; Varenicline (Primary)
- Indications Smoking withdrawal
- Focus Therapeutic Use
- 04 Nov 2015 New trial record